**Question:** Carcinoma Ex pleomorphic adenoma is

A. Squamous cell carcinoma
B. Adenocarcinoma
C. Basal cell carcinoma
D. Squamous cell carcinoma ex pleomorphic adenoma

**Core Concept:** Carcinoma Ex Pleomorphic Adenoma (CEPA) is a rare type of malignancy that arises from a pre-existing pleomorphic adenoma, a benign mixed tumor of the salivary glands. Pleomorphic adenoma is characterized by a coexistence of benign epithelial and mesenchymal components. CEPA represents the malignant transition from a benign pleomorphic adenoma, leading to an aggressive and locally invasive malignancy.

**Why the Correct Answer is Right:** D. Squamous cell carcinoma ex pleomorphic adenoma is the correct answer because it represents the malignant change from a benign pleomorphic adenoma. In CEPA, the epithelial component (squamous cells) undergoes malignant change, leading to a squamous cell carcinoma. The "ex" in CEPA signifies the origin from the pre-existing benign pleomorphic adenoma.

**Why Each Wrong Option is Incorrect:**

A. Squamous cell carcinoma is a common type of carcinoma, but it is not specific to CEPA. Squamous cell carcinoma can arise de novo (from scratch) without a history of a benign tumor.

B. Adenocarcinoma is a type of carcinoma derived from glandular epithelial cells. CEPA involves squamous cell carcinoma, not adenocarcinoma.

C. Basal cell carcinoma is a specific type of skin cancer, distinct from CEPA, which occurs in salivary glands.

**Clinical Pearl:** CEPA is a rare and aggressive malignancy, highlighting the importance of regular follow-up and surveillance for malignant change in pleomorphic adenomas, especially in high-risk patients. Early detection and treatment are crucial to prevent local invasion and distant spread of the tumor.